19 results
8-K
EX-99.1
COGT
Cogent Biosciences Inc
15 Mar 22
Cogent Biosciences Provides Corporate Updates, Fourth Quarter
8:08am
.
Appointed Lora Marden as Vice President, Patient Advocacy, Engagement and Innovation
Ms. Marden joins with over 15 years of rare disease
8-K
EX-10.1
COGT
Cogent Biosciences Inc
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
:
JANUS HENDERSON BIOTECH INNOVATION MASTER FUND LIMITED
By: Janus Henderson Investors US LLC, its investment advisor
By:
/s/ Agustin Mohedas
Name …
Fairmount Healthcare Fund II L.P.
Janus Henderson Biotech Innovation Master Fund Limited
N/A
Perceptive Life Sciences Master Fund, Ltd.
TCG Crossover
8-K
EX-10.2
COGT
Cogent Biosciences Inc
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
above.
JANUS HENDERSON BIOTECH INNOVATION MASTER FUND LIMITED
By: Janus Henderson Investors US LLC, its investment advisor
By:
/s/ Agustin Mohedas
10-K
2018 FY
COGT
Cogent Biosciences Inc
28 Mar 19
Annual report
7:31am
.
Second, in 2012, Congress enacted the Food and Drug Administration Safety and Innovation Act (FDASIA). This law established a new regulatory scheme … 2010, included a subtitle called the Biologics Price Competition and Innovation Act of 2009 (BPCIA). The BPCIA established a regulatory scheme
424B5
ffbj9ad 0l515sfx8
2 Dec 20
Prospectus supplement for primary offering
5:06pm
424B5
3xf9iiamhdob4c i2a
30 Nov 20
Prospectus supplement for primary offering
5:28pm
8-K
EX-10.1
uhbrvkg8ihgb ci
6 Jul 20
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
10:31am
10-Q
rtwnhub1wnn11qb0
14 May 18
Quarterly report
7:01am
- Prev
- 1
- Next